• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Unspecified (PubMed=12794755).
  

PubMed=1710138; PMCID=PMC2204105
Toyoaki Hida, Koichi Koike, Yoshitaka Sekido, Keiko Nishida, Takahiko Sugiura, Yutaka Ariyoshi, Toshitada Takahashi, Ryuzo Ueda;
Epitope analysis of cluster 1 and NK cell-related monoclonal antibodies.
Br. J. Cancer Suppl. 14:24-28(1991)

PubMed=8384671; DOI=10.1093/oxfordjournals.jjco.a039602
Toyoaki Hida, Yutaka Ariyoshi, Masaki Kuwabara, Takahiko Sugiura, Takashi Takahashi, Toshitada Takahashi, Kenji Hosoda, Yoshiro Niitsu, Ryuzo Ueda;
Glutathione S-transferase pi levels in a panel of lung cancer cell lines and its relation to chemo-radiosensitivity.
Jpn. J. Clin. Oncol. 23:14-19(1993)

PubMed=8385084; DOI=10.1111/j.1349-7006.1993.tb02851.x; PMCID=PMC5919128
Susumu Suzuki, Takashi Takahashi, Shigeo Nakamura, Koichi Koike, Yutaka Ariyoshi, Toshitada Takahashi, Ryuzo Ueda;
Alterations of integrin expression in human lung cancer.
Jpn. J. Cancer Res. 84:168-174(1993)

PubMed=7834619
Osuke Washimi, Masaaki Nagatake, Hirotaka Osada, Ryuzo Ueda, Takashi Koshikawa, Tsuneo Seki, Toshitada Takahashi, Takashi Takahashi;
In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers.
Cancer Res. 55:514-517(1995)

PubMed=12107105; DOI=10.1016/S0002-9440(10)64172-7; PMCID=PMC1850681
Sana Yokoi, Kohichiroh Yasui, Fumiko Saito-Ohara, Katsumi Koshikawa, Toshihiko Iizasa, Takehiko Fujisawa, Takeo Terasaki, Akira Horii, Takashi Takahashi, Setsuo Hirohashi, Johji Inazawa;
A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers.
Am. J. Pathol. 161:207-216(2002)

PubMed=12794755; DOI=10.1002/ijc.11184
Hideki Endoh, Yasushi Yatabe, Shigeki Shimizu, Kohei Tajima, Hiroyuki Kuwano, Takashi Takahashi, Tetsuya Mitsudomi;
RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.
Int. J. Cancer 106:45-51(2003)